NVIDIA’s GeForce Partner Program Allegedly Engages In Anti-Consumer Practices

Usman Pirzada

Kyle Bennett, Editor-in-Chief of HardOCP has published a report which could open a new chapter of litigation for NVIDIA and something that, if true, is very much reminiscent of practices that came to light in the CPU industry a few years back with Intel and AMD locking horns and a $1 billion fine. The report details the 'NVIDIA Geforce Partner Program', a program that was made public some time ago but seems to be a mostly boring affair on the surface.

NVIDIA employing anti-consumer and monopolistic practices to take market-share from AMD according to HardOCP report

The report by Kyle on the other hand, alleges something completely different: an anti-competitive, and monopolistic program, that is designed to remove the element of consumer choice from most OEM designs. They will reportedly achieve this by using a wide variety of written and unwritten incentives. The tale goes like this: any OEM who agrees to align a high end gaming brand exclusively with GeForce will be considered a GeForce partner and will get a lot of written benefits - including help with marketing material. There are also some implied unwritten incentives according to the report, which include priority allocation of GPUs for GPP members as well as channel discounts.

He went on to give the following example:

The example that will likely resonate best with HardOCP readers is the ASUS Republic of Gamers brand. I have no knowledge if ASUS is a GPP partner, I am simply using the ROG brand hypothetically. If ASUS is an NVIDIA GPP partner, and it wants to continue to use NVIDIA GPUs in its ROG branded video cards, computers, and laptops, it can no longer sell any other company's GPUs in ROG products. So if ASUS want to keep building NVIDIA-based ROG video cards, it can no longer sell AMD-based ROG video cards, and be a GPP partner.

Kyle's report states he reached out to seven companies part of the GPP program and was unable to get anyone to speak about the program on the record - those that did so - did it anonymously. The reasons he lists are " fear of losing their jobs, or having retribution placed upon them or their companies by NVIDIA". The general tone of his conversations with partners was like so:

  • They think that it has terms that are likely illegal
  • GPP is likely going to tremendously hurt consumers' choices
  • It will disrupt business with the companies that they are currently doing business with, namely AMD and Intel

Of course, its up to the OEM/AIB to be part of the GPP program, but should they decide not to join. They will lose the following benefits:

  • high-effort engineering engagements
  • early tech engagement
  • launch partner status
  • game bundling
  • sales rebate programs
  • social media and PR support
  • marketing reports
  • marketing development funds (MDF)

Most of the contracts for GPP have been signed and if the company's own statements are to be believed they have the wide majority of players already in the contract. As Kyle mentions, this is one of those things that are going to take years in court before any conclusion is reached and anything is proved. Regardless of what happens though, this is going to be sure to turn a lot of attention NVIDIA's way now.

The primary problem with the program is the apparent disconnect between the written and the unwritten. GPU dies are scarce, it is not like there is an abundance to go around and NVIDIA can choose who to allocate its product to. We have already seen examples of this before (where NVIDIA would only hand out the high end GPUs to AIBs if the AIB in question had sold a set quantity of low end GPUs first - usually an order of magnitude larger) so it is clear that there is some history of priority allocation - whether or not such an allocation is written down anywhere.

Of course there are such things as IHV exclusive brands, such as Sapphire - but the key there is disclosure. If OEMs do not disclose the fact that they are only offering NVIDIA GPUs and give the illusion that they did so because it was the highest performing tech (regardless of whether it actually is or not) - then it leads to consumers being hurt. My own failed attempts at trying to get someone to talk did tell me this much however: all but a few OEMs have been signed on. In fact, the number of OEMs that hadn't agreed to the GPP program could be counted on one hand.

Its also worth noting that when I talked to them, NVIDIA stated that there are no lock-in contracts and all OEMs are free to leave the program anytime they want. The legality of the program as it stands is something I will not comment on, with details so hazy right now, but I will ask this: would you choose an OEM brand that you know has aligned exclusively with NVIDIA, or would you prefer to retain the choice of choosing your favorite vendor?

Key Disclosures: NVIDIA has completely denied on-the-record the existence of all anti-consumer practices alleged in the report and have stated while the program exists, there are no MDFs/discounts/priority allocation associated with aligning a gaming brand exclusively with NVIDIA. In the interest of complete disclosure and transparency I will also mention that AMD reached out to me stating that they had received tip-offs from multiple partners who stated (on the condition of anonymity) that the program existed a few weeks back.

The initial information provided to me seemed very interesting so I picked up the thread and reached out to some of my contacts and do my due diligence. Unfortunately pretty much any OEM/AIB I reached out to refused to talk about GPP on-the-record and only one AIB, on the condition of anonymity, hinted at the existence of the program. Armed with just one anonymous record and NVIDIA's complete denial, it was hard to roll out an unbiased piece, but it looks like Kyle has had a lot better luck than us (and elbow grease!) and has done enough legwork to finally move forward with a fleshed out story.

This is a developing story and might be updated.

Share this story

Deal of the Day

Comments